Skip to main content

Spiros Jamas

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Spiros Jamas

Earlier roles on record: CEO at Entera Bio Ltd. (ENTX) until July 15, 2022. Entera Bio Ltd. reported in an 8-K filed July 18, 2022 that Spiros Jamas resigned as officer as well as a member of any board of directors, and any committee thereto, throughout the Company Group, effective July 15, 2022. Entera Bio Ltd. reported in an 8-K filed July 18, 2022 that Spiros Jamas resigned as Chief Executive Officer, effective July 15, 2022. The proxy statement of Entera Bio Ltd. reports total compensation of $1,143 for Spiros Jamas in fiscal 2021, including a base salary of $392.

“You acknowledge and agree that, effective as of the Termination Date, you will be deemed to have resigned from all positions then held as an officer as well as a member of any board of directors, and any committee thereto, throughout the Company Group.”
Entera Bio Ltd. Form 8-K, filed July 18, 2022 · Read the filing
“On July 13, 2022, the Company and Dr. Spiros Jamas, the Company’s former Chief Executive Officer, entered into a mutual separation agreement (the “Separation Agreement”), pursuant to which the parties agreed that Dr. Jamas would resign from his position as the Company’s Chief Executive Officer, effective July 15, 2022 (the “Separation Date”).”
Entera Bio Ltd. Form 8-K, filed July 18, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Entera Bio Ltd. (ENTX) $392 $1,143

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.